VIPANLO

Serial Number 90898810
606

Registration Progress

Application Filed
Aug 24, 2021
Under Examination
Aug 2, 2022
Approved for Publication
Jun 7, 2022
Published for Opposition
Jun 7, 2022
Registered

Trademark Image

VIPANLO

Basic Information

Serial Number
90898810
Filing Date
August 24, 2021
Published for Opposition
June 7, 2022
Abandonment Date
March 6, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 6, 2023
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Andrea Christensen

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Mar 6, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 6, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 2, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 7, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 7, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 18, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 5, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for cholesterol level reduction; pharmaceutical preparations for triglyceride level reduction

Classification

International Classes
005